GPR30 Articles


  • Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.

    Prostate cancer (PCa) treatment was first established by Huggins and Hodges in 1941, primarily described as androgen deprivation via interference of testicular androgen production. The disease remains incurable with relapse of hormone-refractory cancer after treatments.

    Published September 5, 2016
  • New Anti-Cancer Strategies in Testicular Germ Cell Tumors.

    The most common solid malignancy of young men aged 20 to 34 years is testicular germ cell tumor. In addition, the incidence of these tumors has significatively increased throughout the last years. Testicular germ cell tumors are classified into seminoma and nonseminoma germ cell tumors, which take in yolk sac tumor, embryonal cell carcinoma, choriocarcinoma, and teratoma.

    Published February 6, 2019
  • Prostate cancer stem cells: the role of androgen and estrogen receptors.

    Prostate cancer is one of the most commonly diagnosed cancers in men, and androgen deprivation therapy still represents the primary treatment for prostate cancer patients. This approach, however, frequently fails and patients develop castration-resistant prostate cancer, which is almost untreatable.

    Published November 3, 2015